Which nucleoside and nucleotide backbone combinations select for the K65R mutation in HIV-1 reverse transcriptase

AIDS. 2004 Apr 9;18(6):949-51. doi: 10.1097/00002030-200404090-00014.
No abstract available

MeSH terms

  • Adenine / analogs & derivatives*
  • Adenine / therapeutic use
  • Antiretroviral Therapy, Highly Active
  • Didanosine / therapeutic use
  • Dideoxynucleosides / therapeutic use
  • Drug Resistance, Multiple, Viral / genetics*
  • HIV Infections / drug therapy*
  • HIV Reverse Transcriptase / genetics*
  • HIV-1 / genetics*
  • Humans
  • Mutation*
  • Nucleosides / genetics
  • Nucleotides / genetics
  • Organophosphonates*
  • Organophosphorus Compounds / therapeutic use
  • Prevalence
  • Tenofovir

Substances

  • Dideoxynucleosides
  • Nucleosides
  • Nucleotides
  • Organophosphonates
  • Organophosphorus Compounds
  • Tenofovir
  • HIV Reverse Transcriptase
  • Adenine
  • Didanosine
  • abacavir